View in EDS

Gastrointestinal toxicity of gemtuzumab ozogamicin: real-life data from the AMLCG, SAL, and CELL study groups.

Saved in:
Bibliographic Details
Title: Gastrointestinal toxicity of gemtuzumab ozogamicin: real-life data from the AMLCG, SAL, and CELL study groups.
Authors: Knabe R; Department of Medicine III, University Hospital Munich (LMU), Munich, Germany., Muller P; Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany.; Department of Emergency Medicine, University Hospital Berlin (Charité), Berlin, Germany., Schliemann C; Department of Medicine A, University Hospital Münster, Münster, Germany., Hanoun M; Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany., Unglaub JM; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany., Weinbergerová B; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University Brno, Brno, Czech Republic., Mayer J; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University Brno, Brno, Czech Republic., Krekeler C; Department of Medicine A, University Hospital Münster, Münster, Germany., Krause SW; Department of Hematology and Medical Oncology, Uniklinikum Erlangen, Erlangen, Germany., Kaufmann M; Department of Hematology, Oncology and Palliative Medicine, Robert-Bosch-Hospital, Stuttgart, Germany., Kraus S; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany., Steffen B; Department of Hematology and Oncology, University Hospital Frankfurt am Main, Frankfurt am Main, Germany., Modemann F; Department of Oncology, Hematology and Bone Marrow Transplantation with Division of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Subklewe M; Department of Medicine III, University Hospital Munich (LMU), Munich, Germany.; Partner Site Munich, German Cancer Consortium (DKTK), Munich, Germany.; Gene Centre, Munich, Germany.; German Cancer Research Centre, Helmholtz Association and German Centers for Health Research, Heidelberg, Germany., Bücklein V; Department of Medicine III, University Hospital Munich (LMU), Munich, Germany., Kunz WG; Department of Radiology, University Hospital Munich (LMU), Munich, Germany., Rudelius M; Department of Pathology, University Hospital Munich (LMU), Munich, Germany., von Bergwelt-Baildon M; Department of Medicine III, University Hospital Munich (LMU), Munich, Germany.; Partner Site Munich, German Cancer Consortium (DKTK), Munich, Germany.; German Cancer Research Centre, Helmholtz Association and German Centers for Health Research, Heidelberg, Germany., Gutmair K; Institute for Medical Information Processing, Biometry, and Epidemiology, IBE, LMU Munich, Munich, Germany., Hoster E; Institute for Medical Information Processing, Biometry, and Epidemiology, IBE, LMU Munich, Munich, Germany., Herold T; Department of Medicine III, University Hospital Munich (LMU), Munich, Germany., Röllig C; Department of Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany., Spiekermann K; Department of Medicine III, University Hospital Munich (LMU), Munich, Germany.; Partner Site Munich, German Cancer Consortium (DKTK), Munich, Germany.
Source: Blood advances [Blood Adv] 2025 Jul 08; Vol. 9 (13), pp. 3336-3339.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39993233
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Gastrointestinal toxicity of gemtuzumab ozogamicin: real-life data from the AMLCG, SAL, and CELL study groups.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Knabe+R%22">Knabe R</searchLink>; Department of Medicine III, University Hospital Munich (LMU), Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Muller+P%22">Muller P</searchLink>; Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany.; Department of Emergency Medicine, University Hospital Berlin (Charité), Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Schliemann+C%22">Schliemann C</searchLink>; Department of Medicine A, University Hospital Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Hanoun+M%22">Hanoun M</searchLink>; Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Unglaub+JM%22">Unglaub JM</searchLink>; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Weinbergerová+B%22">Weinbergerová B</searchLink>; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University Brno, Brno, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Mayer+J%22">Mayer J</searchLink>; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University Brno, Brno, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Krekeler+C%22">Krekeler C</searchLink>; Department of Medicine A, University Hospital Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Krause+SW%22">Krause SW</searchLink>; Department of Hematology and Medical Oncology, Uniklinikum Erlangen, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Kaufmann+M%22">Kaufmann M</searchLink>; Department of Hematology, Oncology and Palliative Medicine, Robert-Bosch-Hospital, Stuttgart, Germany.<br /><searchLink fieldCode="AU" term="%22Kraus+S%22">Kraus S</searchLink>; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Steffen+B%22">Steffen B</searchLink>; Department of Hematology and Oncology, University Hospital Frankfurt am Main, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Modemann+F%22">Modemann F</searchLink>; Department of Oncology, Hematology and Bone Marrow Transplantation with Division of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Subklewe+M%22">Subklewe M</searchLink>; Department of Medicine III, University Hospital Munich (LMU), Munich, Germany.; Partner Site Munich, German Cancer Consortium (DKTK), Munich, Germany.; Gene Centre, Munich, Germany.; German Cancer Research Centre, Helmholtz Association and German Centers for Health Research, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Bücklein+V%22">Bücklein V</searchLink>; Department of Medicine III, University Hospital Munich (LMU), Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Kunz+WG%22">Kunz WG</searchLink>; Department of Radiology, University Hospital Munich (LMU), Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Rudelius+M%22">Rudelius M</searchLink>; Department of Pathology, University Hospital Munich (LMU), Munich, Germany.<br /><searchLink fieldCode="AU" term="%22von+Bergwelt-Baildon+M%22">von Bergwelt-Baildon M</searchLink>; Department of Medicine III, University Hospital Munich (LMU), Munich, Germany.; Partner Site Munich, German Cancer Consortium (DKTK), Munich, Germany.; German Cancer Research Centre, Helmholtz Association and German Centers for Health Research, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Gutmair+K%22">Gutmair K</searchLink>; Institute for Medical Information Processing, Biometry, and Epidemiology, IBE, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Hoster+E%22">Hoster E</searchLink>; Institute for Medical Information Processing, Biometry, and Epidemiology, IBE, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Herold+T%22">Herold T</searchLink>; Department of Medicine III, University Hospital Munich (LMU), Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Röllig+C%22">Röllig C</searchLink>; Department of Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Spiekermann+K%22">Spiekermann K</searchLink>; Department of Medicine III, University Hospital Munich (LMU), Munich, Germany.; Partner Site Munich, German Cancer Consortium (DKTK), Munich, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2025 Jul 08; Vol. 9 (13), pp. 3336-3339.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39993233
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/bloodadvances.2024014570
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3336
    Titles:
      – TitleFull: Gastrointestinal toxicity of gemtuzumab ozogamicin: real-life data from the AMLCG, SAL, and CELL study groups.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Knabe R
      – PersonEntity:
          Name:
            NameFull: Muller P
      – PersonEntity:
          Name:
            NameFull: Schliemann C
      – PersonEntity:
          Name:
            NameFull: Hanoun M
      – PersonEntity:
          Name:
            NameFull: Unglaub JM
      – PersonEntity:
          Name:
            NameFull: Weinbergerová B
      – PersonEntity:
          Name:
            NameFull: Mayer J
      – PersonEntity:
          Name:
            NameFull: Krekeler C
      – PersonEntity:
          Name:
            NameFull: Krause SW
      – PersonEntity:
          Name:
            NameFull: Kaufmann M
      – PersonEntity:
          Name:
            NameFull: Kraus S
      – PersonEntity:
          Name:
            NameFull: Steffen B
      – PersonEntity:
          Name:
            NameFull: Modemann F
      – PersonEntity:
          Name:
            NameFull: Subklewe M
      – PersonEntity:
          Name:
            NameFull: Bücklein V
      – PersonEntity:
          Name:
            NameFull: Kunz WG
      – PersonEntity:
          Name:
            NameFull: Rudelius M
      – PersonEntity:
          Name:
            NameFull: von Bergwelt-Baildon M
      – PersonEntity:
          Name:
            NameFull: Gutmair K
      – PersonEntity:
          Name:
            NameFull: Hoster E
      – PersonEntity:
          Name:
            NameFull: Herold T
      – PersonEntity:
          Name:
            NameFull: Röllig C
      – PersonEntity:
          Name:
            NameFull: Spiekermann K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 07
              Text: 2025 Jul 08
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2473-9537
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 13
          Titles:
            – TitleFull: Blood advances
              Type: main
ResultId 1